Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. PLTR
4. SPY
5. KTOS
6. AON
7. TMUS
8. LBRX
9. BMY
10. MRK

Go back to Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 4c

Citi Upgrades Ionis Pharmaceuticals (IONS) to Neutral

May 4, 2023 6:27 AM EDT

Citi analyst David Lebowitz upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from Sell to Neutral with a price target of $36.00 (from $30.00).

The analyst comments "Upgrading to Neutral, Raising PT to $36 (+$6) Eplontersen prospects in ATTR is a key driver for LT growth. Recently reported full data continues to suggest eplontersen is... More